Table 1.
Demographic data and vascular risk factors in nasopharyngeal carcinoma patients and normal controls
| NPC Patients (n = 105) | Controls (n = 25) | p value | |
|---|---|---|---|
| Age, y |
52.43 ± 10.23 |
50.68 ± 11.49 |
0.280 |
|
Gender (female; male) |
33; 72 |
9; 16 |
0.660 |
|
Body mass index, kg/m
2
|
23.78 ± 3.61 |
22.61 ± 2.95 |
0.142 |
|
Median (IQR)duration after radiotherapy (months) |
48 (31, 77) |
--- |
|
|
Right CCA IMT, mm |
1.025 ± 0.611 |
0.612 ± 0.074 |
<0.001 |
|
Left CCA IMT, mm |
1.036 ± 0.541 |
0.643 ± 0.111 |
<0.001 |
|
Mean CCA IMT, mm |
1.031 ± 0.539 |
0.634 ± 0.111 |
<0.001 |
|
Cholesterol, mg/dL |
|
|
|
|
Total |
201.96 ± 37.52 |
187.17 ± 24.28 |
0.021 |
|
HDL-C |
61.07 ± 15.23 |
67.62 ± 14.55 |
0.059 |
|
LDL-C |
118.22 ± 35.06 |
102.13 ± 18.39 |
0.003 |
|
Triglyceride, mg/dL |
114.39 ± 63.82 |
86.83 ± 35.74 |
0.006 |
|
Glucose, mg/dL |
90.96 ±14.03 |
86.79 ± 8.12 |
0.165 |
|
HBA1c |
5.70 ± 0.47 |
5.56 ± 0.23 |
0.146 |
|
hs-CRP, mg/L |
3.50 ± 1.38 |
1.12 ± 1.00 |
<0.001 |
|
WBC counts (X10
3
/mL) |
4.86 ± 1.62 |
5.32 ± 1.02 |
0.189 |
|
RBC counts (X10
6
/ml) |
4.61 ± 0.67 |
4.95 ± 0.49 |
0.035 |
| Platelet counts (X10 3 /mL) | 225.74 ± 64.74 | 207.75 ± 39.44 | 0.195 |
Values are expressed in mean ± SD unless otherwise indicated.
Abbreviations: IQR inter-quartile range, HBA1c glycosylated hemoglobin.